Comparison of Endothelial Function in Patients with Metabolic Syndrome on Bezafibrate or Atorvastatin Therapy

By Hanefeld Christoph   Bulut-Streich Nadine   Bulut Daniel   Graf Claudia   Mügge Andreas   Spiecker Martin  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 2, 2005-03 ,pp. : 153-155

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-01 ,pp. : 5025-5038

Bentham Science Publishers

Access to resources Recommend Favorite

Transgenerational Inheritance in the Offspring of Pregnant Women with Metabolic Syndrome

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 1, 2014-06 ,pp. : 13-23

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of canrenone in patients with metabolic syndrome

By Derosa Giuseppe   Bonaventura Aldo   Bianchi Lucio   Romano Davide   D'Angelo Angela   Fogari Elena   Maffioli Pamela  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2161-2169

Informa Healthcare

Access to resources Recommend Favorite

Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus

By Reyes-Soffer Gissette   Rondon-Clavo Carlos   Ginsberg Henry N  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1429-1438

Informa Healthcare

Access to resources Recommend Favorite